Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-17-065008

Director acquired 20,000 shares (option exercise)

  • Director gave up 12,325 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
WEISER MICHAEL Director 2017-12-08 Option exercise +20,000 $2.73 $54,600 225,370 D
WEISER MICHAEL Director 2017-12-08 Shares withheld for taxes −12,325 $4.43 $54,600 213,045 D
Derivatives
WEISER MICHAEL Director 2017-12-08 Option exercise · Stock Option (right to buy) −20,000 0 D
Loading xslF345X03/doc4.xml…